Gait and Alzheimer Interaction Tracking (GAIT) Study

NCT01315717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 912

Last updated 2016-09-22

No results posted yet for this study

Summary

The purpose of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).

Conditions

  • Gait Apraxia
  • Alzheimer Disease
  • Impaired Cognition
  • Cerebral Atrophy

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Olivier Beauchet, MD, PhD · Angers University Hospital

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315717 on ClinicalTrials.gov